Literature DB >> 7677215

Babesiosis in Wisconsin: a potentially fatal disease.

B L Herwaldt1, F E Springs, P P Roberts, M L Eberhard, K Case, D H Persing, W A Agger.   

Abstract

Babesiosis is emerging as an important tick-borne zoonosis in the United States. Most reported cases of this parasitic disease have been acquired in the Northeast. To date, only two clinical cases of Babesia microti infection acquired in the upper Midwest have been described. We report eight more cases. Most if not all of the 10 total cases probably were acquired in northwestern Wisconsin. Three cases (30% of 10) we now report were fatal and occurred in elderly patients (65-75 years old) who died after complicated hospital courses. One patient probably had had a latent Babesia infection that activated because of immunosuppression attributable to high-dose corticosteroid therapy and to splenic infarctions caused by cholesterol emboli. All three fatal cases were diagnosed incidentally and highlight the importance of considering the diagnosis of babesiosis in febrile patients who have been in babesiosis-endemic areas; examining their blood smears carefully; and treating promptly with clindamycin and quinine, and, if indicated, exchange transfusion. Medical personnel should be knowledgeable about this zoonosis, which is not limited to the northeastern United States, and is potentially serious, sometimes fatal.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677215     DOI: 10.4269/ajtmh.1995.53.146

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture.

Authors:  U G Munderloh; J E Madigan; J S Dumler; J L Goodman; S F Hayes; J E Barlough; C M Nelson; T J Kurtti
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Current indications for the use of clindamycin: A critical review.

Authors:  M Smieja
Journal:  Can J Infect Dis       Date:  1998-01

4.  Detection of enzootic babesiosis in baboons (Papio cynocephalus) and phylogenetic evidence supporting synonymy of the genera Entopolypoides and Babesia.

Authors:  M A Bronsdon; M J Homer; J M Magera; C Harrison; R G Andrews; J T Bielitzki; C L Emerson; D H Persing; T R Fritsche
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Fatal multiple deer tick-borne infections in an elderly patient with advanced liver disease.

Authors:  Shiven Chabria; Onyema Ogbuagu
Journal:  BMJ Case Rep       Date:  2015-03-02

6.  Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.

Authors:  S E Marley; M L Eberhard; F J Steurer; W L Ellis; P B McGreevy; T K Ruebush
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Endemic babesiosis in another eastern state: New Jersey.

Authors:  Barbara L Herwaldt; Paul C McGovern; Michal P Gerwel; Rachael M Easton; Rob Roy MacGregor
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

Review 8.  Cultivation of Babesia and Babesia-like blood parasites: agents of an emerging zoonotic disease.

Authors:  Frederick L Schuster
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 9.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

10.  Babesiosis: An Update on Epidemiology and Treatment.

Authors:  Jeffrey A. Gelfand; Michael V. Callahan
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.